NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health announced a quarterly dividend on Wednesday, May 9th. Investors of record on Monday, July 2nd will be given a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 dividend on an annualized basis and a dividend yield of 3.51%. The ex-dividend date is Friday, June 29th. This is an increase from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

Cardinal Health announced that its board has initiated a stock buyback program on Thursday, February 8th 2018, which permits the company to buyback $1,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to buy shares of its stock through open market purchases. Shares buyback programs are often an indication that the company's management believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) released its earnings results on Thursday, May, 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts' consensus estimates of $1.51 by $0.12. The firm earned $33.63 billion during the quarter, compared to the consensus estimate of $33.61 billion. Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

Cardinal Health issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.42.

15 equities research analysts have issued 1 year price objectives for Cardinal Health's shares. Their forecasts range from $55.00 to $85.00. On average, they expect Cardinal Health's stock price to reach $69.7692 in the next twelve months. View Analyst Ratings for Cardinal Health.

Cardinal Health saw a decline in short interest in the month of May. As of May 15th, there was short interest totalling 9,109,975 shares, a decline of 33.6% from the April 30th total of 13,723,348 shares. Based on an average trading volume of 5,195,453 shares, the short-interest ratio is currently 1.8 days. Currently, 2.9% of the shares of the stock are sold short. View Cardinal Health's Current Options Chain.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

Media stories about CAH stock have trended somewhat positive recently, Accern reports. Accern rates the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cardinal Health earned a media sentiment score of 0.09 on Accern's scale. They also gave news headlines about the company an impact score of 46.40 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Cardinal Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.73%), Barrow Hanley Mewhinney & Strauss LLC (5.98%), American International Group Inc. (2.51%), Boston Partners (1.94%), Franklin Resources Inc. (1.81%) and Northern Trust Corp (1.37%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Element Capital Management LLC, Franklin Resources Inc., JPMorgan Chase & Co., American Century Companies Inc., BlackRock Inc., Thompson Siegel & Walmsley LLC, LSV Asset Management and DekaBank Deutsche Girozentrale. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was purchased by a variety of institutional investors in the last quarter, including Boston Partners, Pzena Investment Management LLC, Point72 Asset Management L.P., Schwab Charles Investment Management Inc., Barrow Hanley Mewhinney & Strauss LLC, Russell Investments Group Ltd., Wedge Capital Management L L P NC and Roystone Capital Management LP. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $54.25.

Cardinal Health has a market capitalization of $16.47 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]